Mellado-Sánchez Gabriela, García-Cordero Julio, Luria-Pérez Rosendo, Lázaro-Olan Lucero, Santos-Argumedo Leopoldo, Gutiérrez-Castañeda Benito, Estrada-García Iris, Cedillo-Barrón Leticia
Departamento de Biomedicina Molecular Centro de Investigación y Estudios Avanzadas del IPN, Mexico, DF Mexico.
Viral Immunol. 2005;18(4):709-21. doi: 10.1089/vim.2005.18.709.
DNA priming-protein boosting is a strategy used to establish strong immunity to a specific pathogen by the use of two different antigens through sequential delivery systems. In this work, two recombinant plasmids were used, one encoding for the dengue virus E protein, which is know to induce neutralizing antibodies (pcDNA 3.1/E), and the other encoding for the Dengue virus nonstructural protein 1 (pcDNA 3.1/NS1), as a source of B- and T-cell epitopes possibly involved in protective immunity. We showed that immunization of BALB/c mice with three priming doses of both plasmids pcDNA 3.1/E and/or pcDNA 3.1/NS1 were able to induce antibody responses to E protein with a single plasmid; in contrast to the antibody response to NS1 protein we observed an additive effect in terms of antibody response. Moreover, using a prime-boost protocol in which both plasmid constructs were co-administrated followed by a boost of homologous GST-E and GST-NS1 recombinant proteins, we observed an increased antibody response to NS1 and to E protein compared to animals vaccinated with the proteins or with dengue constructs alone. If neutralizing antibodies play an important role in dengue infection, antibodies generated with this regimen was also significantly better than the administration of the mix of proteins alone. These results suggest that NS1 and E proteins together could be considered in a design of subunit recombinant vaccines.
DNA 初免-蛋白加强免疫是一种通过使用两种不同抗原经序贯递送系统来建立针对特定病原体的强大免疫力的策略。在本研究中,使用了两种重组质粒,一种编码登革病毒 E 蛋白(已知其可诱导中和抗体,即 pcDNA 3.1/E),另一种编码登革病毒非结构蛋白 1(pcDNA 3.1/NS1),后者作为可能参与保护性免疫的 B 细胞和 T 细胞表位的来源。我们发现,用 pcDNA 3.1/E 和/或 pcDNA 3.1/NS1 这两种质粒的三个初免剂量免疫 BALB/c 小鼠,能够用单个质粒诱导针对 E 蛋白的抗体反应;与针对 NS1 蛋白的抗体反应不同,我们在抗体反应方面观察到了累加效应。此外,采用一种初免-加强方案,即同时给予两种质粒构建体,随后用同源的 GST-E 和 GST-NS1 重组蛋白进行加强免疫,我们观察到与单独用这些蛋白或登革构建体免疫的动物相比,针对 NS1 和 E 蛋白的抗体反应有所增强。如果中和抗体在登革热感染中起重要作用,那么用该方案产生的抗体也明显优于单独给予蛋白混合物。这些结果表明,在亚单位重组疫苗的设计中可以考虑将 NS1 和 E 蛋白结合起来。